This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Everfront Biotech Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tsung-Lang Chiu and His Patent on Meningioma Treatment.
Introduction
Tsung-Lang Chiu is an inventor associated with Taipei, Taiwan, and Everfront Biotech Inc. His patent work focuses on a proposed pharmaceutical use of phthalide compounds in treating meningioma and reducing its recurrence.
Latest Patents
Chiu is associated with 1 patent: “Use of Phthalide Compounds in Treatment of Meningioma.” The invention describes using compounds of formulas (I) and (II), or their pharmaceutically acceptable salts, to treat meningioma and reduce the likelihood of recurrence. The patent defines possible substituents for the compounds, including alkyl, cycloalkyl, aryl, alkoxy, aryloxy, and halogen groups.
Career Highlights
Chiu’s listed patent reflects work at the intersection of pharmaceutical chemistry and potential therapeutic applications. His association with Everfront Biotech Inc. connects his inventive activity with a biotechnology company.
Collaborations
Chiu’s listed coworkers include Shinn-Zong Lin and Tzyy-Wen Chiou. Their shared association provides context for the professional network surrounding his patent activity.
Conclusion
Tsung-Lang Chiu’s patent centers on the potential use of phthalide compounds to treat meningioma and reduce recurrence, highlighting his contribution to biotechnology-related invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile